Research Article | | Peer-Reviewed

Prevalence of Renal Dysfunction Among Patients with Chronic Heart Failure

Received: 13 April 2026     Accepted: 22 April 2026     Published: 30 April 2026
Views:       Downloads:
Abstract

Chronic heart failure is a major global health problem associated with substantial morbidity and mortality, and its close interaction with renal function through the cardiorenal syndrome significantly influences disease progression and outcomes. Renal dysfunction is commonly encountered in patients with chronic heart failure and is known to be associated with adverse prognosis; however, its burden in routine clinical settings, particularly in local populations, remains insufficiently characterized. The purpose of this study was to determine the prevalence of renal dysfunction among patients with chronic heart failure and to examine its association with key clinical variables. To achieve this, a hospital-based cross-sectional study was conducted in the Department of Cardiology at Satkhira Medical College and Hospital, Bangladesh, including 150 patients diagnosed with chronic heart failure. Relevant demographic and clinical data were collected, and renal function was assessed using estimated glomerular filtration rate calculated by the CKD-EPI equation. Statistical analysis was performed to evaluate the relationship between renal dysfunction and selected variables. The findings demonstrated that renal dysfunction was present in 58.0% of patients, with moderate impairment being the most common pattern, and was significantly associated with older age, hypertension, diabetes mellitus, and advanced NYHA functional class. In conclusion, this study highlights the substantial burden of renal dysfunction among patients with chronic heart failure and emphasizes the importance of routine renal function assessment for early identification and improved clinical management in this high-risk population.

Published in International Journal of Cardiovascular and Thoracic Surgery (Volume 12, Issue 3)
DOI 10.11648/j.ijcts.20261203.12
Page(s) 92-98
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2026. Published by Science Publishing Group

Keywords

Chronic Heart Failure, Renal Dysfunction, Prevalence, Cardiorenal Syndrome, Glomerular Filtration Rate

1. Introduction
Heart failure is currently recognized as a major global health concern affecting populations worldwide. It is estimated that approximately 38 million individuals are living with heart failure, and evidence suggests that its prognosis may be poorer than that of certain malignancies . Chronic heart failure (CHF) is a highly prevalent condition and represents a significant cause of hospital admissions, being strongly associated with considerable morbidity and mortality .
The relationship between the heart and kidneys in patients with heart failure is complex, and the bidirectional interactions between these two organs are not yet fully understood. The concept of cardiorenal syndrome (CRS) describes a multifaceted disorder in which acute or chronic dysfunction of one organ can induce acute or chronic dysfunction in the other . Heart failure and kidney disease share overlapping pathophysiological mechanisms, resulting in interconnected dysfunction referred to as cardiorenal syndrome . As heart failure advances, compensatory mechanisms such as renal vasoconstriction occur, leading to reduced renal blood flow as circulation is preferentially maintained to vital organs including the heart, brain, and skeletal muscles during activity .
Renal dysfunction is frequently observed among patients with heart failure, with reported prevalence rates ranging from 20% to 57% in those with stable chronic heart failure . Renal impairment acts as an independent contributor to disease progression and is associated with an increased incidence of cardiovascular events and mortality in both asymptomatic and symptomatic CHF populations . Despite incomplete understanding of the underlying mechanisms, patients with heart failure who develop chronic kidney disease (CKD) or worsening renal function (WRF) generally experience poorer clinical outcomes compared to those without renal involvement . Renal dysfunction may indicate more advanced vascular disease, older age, impaired cardiac performance, or a reduced likelihood of receiving optimal therapeutic interventions. Glomerular filtration rate (GFR) is considered one of the earliest and most important indicators for assessing renal function .
Renal dysfunction is commonly observed in patients with heart failure across different clinical settings. In patients with chronic stable heart failure, higher rates have been documented in patients hospitalized with acutely decompensated heart failure . Similarly, other studies have reported that impaired renal function occurs in a substantial proportion of CHF patients. Chronic kidney disease is also commonly present in nearly half of heart failure patients, largely due to shared risk factors contributing to both conditions .
However, many of the existing studies have primarily included younger populations with fewer comorbidities compared to those encountered in routine clinical practice. In addition, patients with significant renal dysfunction have often been excluded from clinical trials . Although some data are available regarding the prevalence and progression of renal dysfunction in hospitalized heart failure patients, there remains a lack of information from representative cohorts of ambulatory patients with chronic heart failure. While several studies have explored the global prevalence of renal dysfunction in heart failure, further research is needed to better understand its burden in real-world clinical settings . Therefore, the present study aims to determine the prevalence of renal dysfunction among patients with chronic heart failure.
2. Methodology & Materials
2.1. Study Design and Setting
This was a hospital-based descriptive cross-sectional study conducted in the Department of Cardiology, Satkhira Medical College and Hospital, Dhaka, Bangladesh, over a one-year period from January 2025 to December 2025.
2.2. Study Population and Sample Size
A total of 150 patients diagnosed with chronic heart failure were included in the study. Patients were recruited from both inpatient and outpatient departments during the study period. The sample size was determined purposively, and participants were enrolled consecutively according to predefined eligibility criteria.
2.3. Inclusion and Exclusion Criteria
Patients of either sex with a confirmed diagnosis of chronic heart failure based on clinical and echocardiographic findings were included in the study. Patients with acute heart failure, known chronic kidney disease on dialysis, congenital heart disease, or incomplete clinical records were excluded.
2.4. Data Collection
Data were collected using a structured data collection form. Relevant information, including age, sex, comorbidities (hypertension and diabetes mellitus), etiology of heart failure, and New York Heart Association (NYHA) functional class, was obtained through patient interviews and review of medical records. NYHA functional class was assessed according to standard clinical criteria. Clinical findings and relevant investigations were also documented.
2.5. Assessment of Renal Function
Renal function was assessed using estimated glomerular filtration rate (eGFR), calculated from serum creatinine using the CKD-EPI equation. Renal dysfunction was defined as eGFR <90 mL/min/1.73 m2 and further categorized as mild (60–89 mL/min/1.73 m2), moderate (30–59 mL/min/1.73 m2), and severe (<30 mL/min/1.73 m2).
2.6. Study Variables
The primary outcome variable was the prevalence of renal dysfunction among patients with chronic heart failure. Independent variables included age, sex, hypertension, diabetes mellitus, and NYHA functional class.
2.7. Statistical Analysis
Data were analyzed using Statistical Package for the Social Sciences (SPSS) version 25.0 (IBM Corp., Armonk, NY, USA). Categorical variables were expressed as frequencies and percentages, while continuous variables were presented as mean ± standard deviation. The association between renal dysfunction and selected clinical variables was assessed using the chi-square test. A p-value of <0.05 was considered statistically significant.
3. Results
3.1. Baseline Characteristics of the Study Population
A total of 150 patients with chronic heart failure were included in the study. The mean age was 55.4 ± 11.3 years, with most patients in the 51–70 years age group (46.7%), followed by 41–50 years (21.3%), ≤40 years (18.7%), and >70 years (13.3%). Males constituted 61.3% of the study population, while females accounted for 38.7%. Hypertension was the most common comorbidity (68.0%), followed by diabetes mellitus (50.7%), and ischemic heart disease was the leading etiology of heart failure (58.7%) (Table 1).
Table 1. Baseline Demographic and Clinical Characteristics of the Study Participants (n = 150).

Variable

Frequency (n)

Percentage (%)

Age Group (years)

≤40

28

18.7

41–50

32

21.3

51–70

70

46.7

>70

20

13.3

Mean Age (years)

55.4 ± 11.3

Sex

Male

92

61.3

Female

58

38.7

Comorbidities

Hypertension

102

68.0

Diabetes Mellitus

76

50.7

Etiology of Heart Failure

Ischemic Heart Disease

88

58.7

Non-ischemic Causes

62

41.3

3.2. Prevalence of Renal Dysfunction
Renal dysfunction (eGFR <90 mL/min/1.73 m2) was present in 58.0% of patients, while 42.0% had normal renal function (Figure 1).
Figure 1. Prevalence of Renal Dysfunction Among Patients with Chronic Heart Failure (n = 150).
3.3. Distribution of Renal Function Based on eGFR
Among the study population, 42.0% had normal renal function (eGFR ≥90 mL/min/1.73 m2). Among those with renal impairment, moderate dysfunction (30–59 mL/min/1.73 m2) was the most frequent category (27.3%), followed by mild dysfunction (18.7%) and severe dysfunction (12.0%), with moderate dysfunction representing the largest proportion (Table 2).
Table 2. Distribution of Renal Function Based on eGFR Among Study Participants (n = 150).

eGFR Category (mL/min/1.73 m2)

Severity

Frequency (n)

Percentage (%)

≥90

Normal

63

42.0

60–89

Mild Dysfunction

28

18.7

30–59

Moderate Dysfunction

41

27.3

<30

Severe Dysfunction

18

12.0

3.4. Association of Renal Dysfunction with Clinical Variables
Renal dysfunction was significantly more common among patients aged ≥60 years (67.5% vs 32.5%, p=0.020), those with hypertension (66.7% vs 33.3%, p=0.001), and those with diabetes mellitus (68.4% vs 31.6%, p=0.030). It was also significantly associated with advanced heart failure, with higher prevalence in NYHA class III–IV compared to class I–II (65.5% vs 42.3%, p=0.004) (Table 3).
Table 3. Association of Renal Dysfunction with Selected Clinical Variables (n = 150).

Variable

Renal Dysfunction Present n (%)

Renal Dysfunction Absent n (%)

p-value

Age ≥60 years

54 (67.5)

26 (32.5)

0.020

Hypertension

68 (66.7)

34 (33.3)

0.001

Diabetes Mellitus

52 (68.4)

24 (31.6)

0.030

NYHA Class III–IV

57 (65.5)

30 (34.5)

0.004

NYHA Class I–II

30 (42.3)

33 (57.7)

-

4. Discussion
In this hospital-based cross-sectional study conducted in the Department of Cardiology at Satkhira Medical College and Hospital, a substantial proportion of patients with chronic heart failure were found to have renal dysfunction as assessed by eGFR. Moderate renal impairment constituted the most common pattern, and renal dysfunction was significantly associated with older age, hypertension, diabetes mellitus, and advanced NYHA functional class. These findings underscore the high burden of renal involvement in chronic heart failure and highlight its close relationship with disease severity and comorbid conditions, emphasizing the need for routine renal function assessment in this patient population.
The baseline demographic and clinical characteristics observed in the present study are largely consistent with previously published literature on chronic heart failure populations. The majority of patients were in the 51–70 years age group, with a mean age of 55.4 ± 11.3 years, indicating a predominance of middle-aged to older adults, which aligns with findings reported by Ahmed et al., where large heart failure registries demonstrated a higher mean age of approximately 65–72 years , and by Shen et al., who reported a median age of 65 years among patients with chronic heart failure . A male predominance was observed in this study (61.3%), which is comparable to Shen et al., where 59.6% of patients were male . Regarding comorbidities, hypertension was the most prevalent condition (68.0%), followed by diabetes mellitus (50.7%), findings that are consistent with data from the ADHERE registry reported by Ahmed et al., where hypertension and diabetes were present in 73% and 44% of patients, respectively . Furthermore, ischemic heart disease was identified as the leading etiology of heart failure (58.7%), in agreement with global evidence indicating coronary artery disease as the most common underlying cause of chronic heart failure. Overall, these findings suggest that the study population is comparable to established heart failure cohorts, thereby supporting the external validity of the present study.
The present study demonstrated that renal dysfunction was present in 58.0% of patients with chronic heart failure, highlighting a substantial burden of impaired renal function in this population. This finding is consistent with previously published studies. Löfman et al. reported a prevalence of 51% for renal dysfunction defined as eGFR <60 mL/min/1.73 m2 , while Lawson et al. observed a higher prevalence of 63% for chronic kidney disease among heart failure patients . Similarly, Cobo et al. reported a prevalence of 59.1% for reduced renal function . Although variations exist due to differences in study populations and definitions of renal dysfunction, the prevalence observed in the present study falls well within the range reported in the literature. These findings reinforce the strong and well-established association between chronic heart failure and renal impairment and highlight the importance of routine assessment of renal function in this patient population.
The present study further demonstrated that among patients with chronic heart failure, 42.0% had normal renal function (eGFR ≥90 mL/min/1.73 m2), while renal dysfunction was distributed across mild (18.7%), moderate (27.3%), and severe (12.0%) categories, with moderate dysfunction being the most frequent abnormality. This pattern is consistent with previous studies reporting a graded decline in renal function among heart failure patients. Löfman et al. similarly observed mild dysfunction in approximately 36%, moderate dysfunction in 43%, and severe dysfunction in 11% of cases , indicating that moderate impairment is commonly the predominant category. Likewise, Stanojević et al. reported mild dysfunction in 57.8%, moderate dysfunction in 32.2%, and severe dysfunction in only about 1.1% , further supporting that early-to-moderate renal impairment is most frequently encountered in chronic heart failure populations. Additionally, Beck et al. demonstrated that worsening renal function, particularly eGFR <30 mL/min/1.73 m2, is associated with a substantially higher burden of heart failure severity and adverse outcomes , emphasizing the clinical significance of advanced renal dysfunction despite its lower prevalence. Overall, the findings of the present study are consistent with existing literature, reinforcing that renal impairment in chronic heart failure most commonly manifests as mild to moderate dysfunction, with a smaller but clinically important proportion progressing to severe impairment.
The present study also demonstrated a significant association between renal dysfunction and several clinical variables in patients with chronic heart failure, with higher prevalence observed among patients aged ≥60 years, those with hypertension, diabetes mellitus, and those in advanced functional class (NYHA III–IV). These findings are consistent with previous literature. Li et al. reported that in patients with NYHA class IV heart failure, renal insufficiency was significantly associated with increasing age, with older patients showing a markedly higher prevalence of reduced eGFR , indicating that renal impairment worsens with advancing age and disease severity. Similarly, Zhang et al. demonstrated that patients with renal dysfunction had significantly higher rates of hypertension compared to those without renal impairment and a substantially greater proportion of NYHA class III–IV patients (40.7% vs 13%, p < 0.001) , highlighting the strong relationship between renal dysfunction and advanced heart failure status. Furthermore, Galil et al. reported a significantly higher prevalence of diabetes mellitus among patients with combined chronic kidney disease and heart failure , supporting the role of diabetes as a major contributing factor to renal impairment in this population. Overall, the findings of the present study align closely with existing evidence, reinforcing that renal dysfunction in chronic heart failure is significantly associated with older age, hypertension, diabetes mellitus, and more advanced NYHA functional class, reflecting the complex and interrelated nature of cardio-renal-metabolic interactions.
5. Conclusion
Renal dysfunction is a common and clinically important comorbidity in patients with chronic heart failure. In this study, more than half of the patients were found to have impaired renal function, with moderate dysfunction being the most frequent pattern. Renal impairment showed significant associations with older age, hypertension, diabetes mellitus, and advanced NYHA class, indicating that worsening renal function is closely linked with increasing disease severity and adverse clinical profiles in chronic heart failure.
Abbreviations

CHF

Chronic Heart Failure

CKD

Chronic Kidney Disease

CKD EPI

Chronic Kidney Disease Epidemiology Collaboration

CRS

Cardiorenal Syndrome

eGFR

Estimated Glomerular Filtration Rate

GFR

Glomerular Filtration Rate

IBM

International Business Machines Corporation

NYHA

New York Heart Association

RD

Renal Dysfunction

SPSS

Statistical Package for the Social Sciences

WRF

Worsening Renal Function

Acknowledgments
I express my sincere gratitude to the staff and participants of the Department of Cardiology, Satkhira Medical College and Hospital, Dhaka, Bangladesh, for their invaluable support during the study period (January–December 2025). I am deeply indebted to my co-author, Reba Das, for her guidance and constant support, and to my family members, well-wishers, and all patients who gave their consent to take part in this study.
Author Contributions
Suman Kumar Das: Conceptualization, Supervision, Project administration, Writing – review & editing
Reba Das: Methodology, Data curation, Investigation
Kajal Kumar Karmoker: Formal Analysis, Validation, Visualization
Nur Alam: Software, Resources, Writing – original draft
Conflicts of Interest
There are no conflicts of interest.
References
[1] Braunwald E. The war against heart failure: the Lancet lecture. The Lancet. 2015 Feb 28; 385(9970): 812-24.
[2] Cowie MR, Mosterd A, Wood D, Deckers JW, Poole-Wilson PA, Sutton G, Grobbee D. The epidemiology of heart failure. European heart journal. 1997 Feb 1; 18(2): 208-25.
[3] Ronco C, McCullough PA, Anker SD, Anand I, Aspromonte N, Bagshaw SM, Bellomo R, Berl T, Bobek I, Cruz DN, Daliento L. Cardiorenal syndromes: an executive summary from the consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contributions to nephrology. 2010 Apr 20; 165: 54-67.
[4] Kamilova U, Abdullaeva C, Zakirova G, Masharipova D, Tagaeva D. Assessment of Kidney Dysfunction in Patients with Chronic Heart Failure. Open Access Macedonian Journal of Medical Sciences. 2022 Sep 10; 10(B): 2093-7.
[5] de Silva R, Nikitin NP, Witte KK, Rigby AS, Goode K, Bhandari S, Clark AL, Cleland JG. Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis. European heart journal. 2006 Mar 1; 27(5): 569-81.
[6] McMurray JJ, Östergren J, Swedberg K, Granger CB, Held P, Michelson EL, Olofsson B, Yusuf S, Pfeffer MA. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial. The Lancet. 2003 Sep 6; 362(9386): 767-71.
[7] SOLVD Investigators*. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. New England Journal of Medicine. 1992 Sep 3; 327(10): 685-91.
[8] Solomon SD, Wang D, Finn P, Skali H, Zornoff L, McMurray JJ, Swedberg K, Yusuf S, Granger CB, Michelson EL, Pocock S. Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation. 2004 Oct 12; 110(15): 2180-3.
[9] Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B. Eplerenone in patients with systolic heart failure and mild symptoms. New England Journal of Medicine. 2011 Jan 6; 364(1): 11-21.
[10] Cleland JG, Carubelli V, Castiello T, Yassin A, Pellicori P, Antony R. Renal dysfunction in acute and chronic heart failure: prevalence, incidence and prognosis. Heart failure reviews. 2012 Mar; 17(2): 133-49.
[11] Costanzo MR. The cardiorenal syndrome in heart failure. Heart failure clinics. 2020 Jan 1; 16(1): 81-97.
[12] Cowie MR, Komajda M, Murray-Thomas T, Underwood J, Ticho B. Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH). European Heart Journal. 2006 May 1; 27(10): 1216-22.
[13] Klein L, Massie BM, Leimberger JD, O’Connor CM, Piña IL, Adams Jr KF, Califf RM, Gheorghiade M. Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF). Circulation: Heart Failure. 2008 May 1; 1(1): 25-33.
[14] Giamouzis G, Kalogeropoulos A, Georgiopoulou V, Laskar S, Smith AL, Dunbar S, Triposkiadis F, Butler J. Hospitalization epidemic in patients with heart failure: risk factors, risk prediction, knowledge gaps, and future directions. Journal of cardiac failure. 2011 Jan 1; 17(1): 54-75.
[15] Smith GL, Lichtman JH, Bracken MB, Shlipak MG, Phillips CO, DiCapua P, Krumholz HM. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. Journal of the American College of Cardiology. 2006 May 16; 47(10): 1987-96.
[16] McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation. 2004 Mar 2; 109(8): 1004-9.
[17] Metra M, Cotter G, Gheorghiade M, Dei Cas L, Voors AA. The role of the kidney in heart failure. European heart journal. 2012 Sep 1; 33(17): 2135-42.
[18] Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O’Connor CM, Pieper K, Sun JL, Yancy CW, Young JB. Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF). Archives of internal medicine. 2007 Jul 23; 167(14): 1493-502.
[19] Heywood JT, Fonarow GC, Costanzo MR, et al. High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail 2007; 13: 422–30.
[20] Jeele MO, Hussein AA, Mohamud MA, Adani AA, Mohamud MF. Spectrum and prevalence of renal dysfunction among heart failure patients attending tertiary care hospital: first report from Somalia. The Egyptian Journal of Internal Medicine. 2023 Oct 5; 35(1): 70.
[21] Levin A, Foley RN. Cardiovascular disease in chronic renal insufficiency. American journal of kidney diseases. 2000 Dec 1; 36(6): S24-30.
[22] Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM, Hendrix GH, Bommer WJ, Elkayam U, Kukin ML, Mallis GI. Effect of oral milrinone on mortality in severe chronic heart failure. New England Journal of Medicine. 1991 Nov 21; 325(21): 1468-75.
[23] Forman DE, Butler J, Wang Y, Abraham WT, O'Connor CM, Gottlieb SS, Loh E, Massie BM, Rich MW, Stevenson LW, Young JB. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. Journal of the American College of Cardiology. 2004 Jan 7; 43(1): 61-7.
[24] Bibbins-Domingo K, Lin F, Vittinghoff E, Barrett-Connor E, Grady D, Shlipak MG. Renal insufficiency as an independent predictor of mortality among women with heart failure. Journal of the American College of Cardiology. 2004 Oct 19; 44(8): 1593-600.
[25] Ahmed A, Campbell RC. Epidemiology of chronic kidney disease in heart failure. Heart Fail Clin. 2008 Oct; 4(4): 387-99.
[26] Shen X, Guo H, Mantica G, Yuan H. Analysis of the clinical features and risk factors of kidney injury in patients with chronic heart failure—a retrospective cohort study. Journal of Thoracic Disease. 2023 Jul 25; 15(7): 3934.
[27] Löfman I, Szummer K, Hagerman I, Dahlström U, Lund LH, Jernberg T. Prevalence and prognostic impact of kidney disease on heart failure patients. Open Heart. 2016 Jan 18; 3(1): e000324.
[28] Lawson CA, Testani JM, Mamas M, Damman K, Jones PW, Teece L, Kadam UT. Chronic kidney disease, worsening renal function and outcomes in a heart failure community setting: A UK national study. Int J Cardiol. 2018 Sep 15; 267: 120-127.
[29] Cobo Marcos M, de la Espriella R, Gayán Ordás J, Llàcer P, Pomares A, Fort A, Ponz de Antonio I, Méndez A, Blázquez-Bermejo Z, Caravaca Pérez P, Rubio Gracia J, Recio-Mayoral A, Zegrí I, García Pinilla JM, Montero Hernández E, Castro A, Soler MJ, Górriz JL, Bascompte Claret R, Fluvià-Brugués P, Manzano L, Núñez J. Prevalence and clinical profile of kidney disease in patients with chronic heart failure. Insights from the Spanish cardiorenal registry. Rev Esp Cardiol (Engl Ed). 2024 Jan; 77(1): 50-59.
[30] Stanojević D, Apostolović S, Janković-Tomasević R, Salinger-Martinović S, Pavlović M, Zivković M, Bozinović N, Kutlesić-Kurtović D. Prevalence of renal dysfunction and its influence on functional capacity in elderly patients with stable chronic heart failure. Vojnosanit Pregl. 2012 Oct; 69(10): 840-5.
[31] Beck H, Titze SI, Hübner S, Busch M, Schlieper G, Schultheiss UT, Wanner C, Kronenberg F, Krane V, Eckardt KU, Köttgen A; GCKD Investigators. Heart failure in a cohort of patients with chronic kidney disease: the GCKD study. PLoS One. 2015 Apr 13; 10(4): e0122552.
[32] Li J, Chu Y, Huang M. Impact of renal dysfunction on prognosis in patients with severe heart failure: A retrospective cohort study. Medicine (Baltimore). 2025 Oct 10; 104(41): e44405.
[33] Zhang H, Shi S, Zhao XJ, Wang JK, Liu ZW, Liu FQ, Zhu L, Zhu SM, Zhang Y, Pan S. Association between the lipid profile and renal dysfunction in the heart failure patients. Kidney and Blood Pressure Research. 2019 Feb 22; 44(1): 52-61.
[34] Galil AG, Pinheiro HS, Chaoubah A, Costa DM, Bastos MG. Chronic kidney disease increases cardiovascular unfavourable outcomes in outpatients with heart failure. BMC nephrology. 2009 Oct 21; 10(1): 31.
Cite This Article
  • APA Style

    Das, S. K., Das, R., Karmoker, K. K., Alam, N. (2026). Prevalence of Renal Dysfunction Among Patients with Chronic Heart Failure. International Journal of Cardiovascular and Thoracic Surgery, 12(3), 92-98. https://doi.org/10.11648/j.ijcts.20261203.12

    Copy | Download

    ACS Style

    Das, S. K.; Das, R.; Karmoker, K. K.; Alam, N. Prevalence of Renal Dysfunction Among Patients with Chronic Heart Failure. Int. J. Cardiovasc. Thorac. Surg. 2026, 12(3), 92-98. doi: 10.11648/j.ijcts.20261203.12

    Copy | Download

    AMA Style

    Das SK, Das R, Karmoker KK, Alam N. Prevalence of Renal Dysfunction Among Patients with Chronic Heart Failure. Int J Cardiovasc Thorac Surg. 2026;12(3):92-98. doi: 10.11648/j.ijcts.20261203.12

    Copy | Download

  • @article{10.11648/j.ijcts.20261203.12,
      author = {Suman Kumar Das and Reba Das and Kajal Kumar Karmoker and Nur Alam},
      title = {Prevalence of Renal Dysfunction Among Patients with Chronic Heart Failure},
      journal = {International Journal of Cardiovascular and Thoracic Surgery},
      volume = {12},
      number = {3},
      pages = {92-98},
      doi = {10.11648/j.ijcts.20261203.12},
      url = {https://doi.org/10.11648/j.ijcts.20261203.12},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcts.20261203.12},
      abstract = {Chronic heart failure is a major global health problem associated with substantial morbidity and mortality, and its close interaction with renal function through the cardiorenal syndrome significantly influences disease progression and outcomes. Renal dysfunction is commonly encountered in patients with chronic heart failure and is known to be associated with adverse prognosis; however, its burden in routine clinical settings, particularly in local populations, remains insufficiently characterized. The purpose of this study was to determine the prevalence of renal dysfunction among patients with chronic heart failure and to examine its association with key clinical variables. To achieve this, a hospital-based cross-sectional study was conducted in the Department of Cardiology at Satkhira Medical College and Hospital, Bangladesh, including 150 patients diagnosed with chronic heart failure. Relevant demographic and clinical data were collected, and renal function was assessed using estimated glomerular filtration rate calculated by the CKD-EPI equation. Statistical analysis was performed to evaluate the relationship between renal dysfunction and selected variables. The findings demonstrated that renal dysfunction was present in 58.0% of patients, with moderate impairment being the most common pattern, and was significantly associated with older age, hypertension, diabetes mellitus, and advanced NYHA functional class. In conclusion, this study highlights the substantial burden of renal dysfunction among patients with chronic heart failure and emphasizes the importance of routine renal function assessment for early identification and improved clinical management in this high-risk population.},
     year = {2026}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Prevalence of Renal Dysfunction Among Patients with Chronic Heart Failure
    AU  - Suman Kumar Das
    AU  - Reba Das
    AU  - Kajal Kumar Karmoker
    AU  - Nur Alam
    Y1  - 2026/04/30
    PY  - 2026
    N1  - https://doi.org/10.11648/j.ijcts.20261203.12
    DO  - 10.11648/j.ijcts.20261203.12
    T2  - International Journal of Cardiovascular and Thoracic Surgery
    JF  - International Journal of Cardiovascular and Thoracic Surgery
    JO  - International Journal of Cardiovascular and Thoracic Surgery
    SP  - 92
    EP  - 98
    PB  - Science Publishing Group
    SN  - 2575-4882
    UR  - https://doi.org/10.11648/j.ijcts.20261203.12
    AB  - Chronic heart failure is a major global health problem associated with substantial morbidity and mortality, and its close interaction with renal function through the cardiorenal syndrome significantly influences disease progression and outcomes. Renal dysfunction is commonly encountered in patients with chronic heart failure and is known to be associated with adverse prognosis; however, its burden in routine clinical settings, particularly in local populations, remains insufficiently characterized. The purpose of this study was to determine the prevalence of renal dysfunction among patients with chronic heart failure and to examine its association with key clinical variables. To achieve this, a hospital-based cross-sectional study was conducted in the Department of Cardiology at Satkhira Medical College and Hospital, Bangladesh, including 150 patients diagnosed with chronic heart failure. Relevant demographic and clinical data were collected, and renal function was assessed using estimated glomerular filtration rate calculated by the CKD-EPI equation. Statistical analysis was performed to evaluate the relationship between renal dysfunction and selected variables. The findings demonstrated that renal dysfunction was present in 58.0% of patients, with moderate impairment being the most common pattern, and was significantly associated with older age, hypertension, diabetes mellitus, and advanced NYHA functional class. In conclusion, this study highlights the substantial burden of renal dysfunction among patients with chronic heart failure and emphasizes the importance of routine renal function assessment for early identification and improved clinical management in this high-risk population.
    VL  - 12
    IS  - 3
    ER  - 

    Copy | Download

Author Information
  • Abstract
  • Keywords
  • Document Sections

    1. 1. Introduction
    2. 2. Methodology & Materials
    3. 3. Results
    4. 4. Discussion
    5. 5. Conclusion
    Show Full Outline
  • Abbreviations
  • Acknowledgments
  • Author Contributions
  • Conflicts of Interest
  • References
  • Cite This Article
  • Author Information